Time is Brain closed an oversubscribed €3M Pre-Series A, only days after receiving CE/MDR approval for its stroke-monitoring platform BraiN20. The Barcelona spinout's device tracks a proprietary brain signal, giving clinicians continuous neurological data from the moment a stroke begins. The company frames this as Real-Time Stroke Intelligence, designed to support decisions across the full patient journey. The dual milestone clears the path for commercial rollout across Europe later this year.